Glutamine:fructose-6-phosphate amidotransferase (GFA) is the rate-limi
ting enzyme in hexosamine biosynthesis, an important pathway for cellu
lar glucose sensing. Human GFA has two potential sites for phosphoryla
tion by cAMP-dependent protein kinase A (PKA). To test whether GFA act
ivity is regulated by cAMP-dependent phosphorylation, rat aortic smoot
h muscle cells were treated in vivo with cAMP-elevating agents, 10 mu
mol/l forskolin, 1 mmol/l 8-Br-cAMP, or 3-isobutyl-1-methylxanthine. A
U treatments resulted in rapid and significant increases (2- to 2.4-fo
ld) in GFA activity assayed in cytosolic extracts. Maximal effects of
forskolin were observed at 10 mu mol/l and 60 min. Preincubation of ce
lls with cycloheximide did not abolish the effect of forskolin. Incuba
tion of cytosolic extracts at 37 degrees C for 10 min in a buffer with
out phosphatase inhibitors led to a 79% decrease of GFA activity. This
loss of activity was inhibited by the addition of phosphatase inhibit
ors (5 mmol/l sodium orthovanadate, 50 mmol/l sodium fluoride, or 5 mm
ol/l EDTA, but not 100 nmol/l okadaic acid), suggesting that GFA under
goes rapid dephosphorylation by endogenous phosphatases. Purified GFA
is phosphorylated in vitro by purified PKA, resulting in a 1.7-fold in
crease in GFA activity. Treatment of GFA with purified protein kinase
C had no effect. We, conclude that GFA activity may be modulated by cA
MP-dependent phosphorylation.